NVZMY - Novonesis A/S (NVZMF) Q4 2024 Earnings Call Transcript
2025-02-26 08:39:34 ET
Novonesis A/S (NVZMF)
Q4 2024 Earnings Conference Call
February 26, 2025 03:00 AM ET
Company Participants
Tobias Cornelius Björklund - Head, Investor Relations
Ester Baiget - Chief Executive Officer
Rainer Lehmann - Chief Financial Officer
Jacob Paulsen - Executive Vice President, Food & Beverage Biosolutions
Amy Byrick - Executive Vice President, Human Health Biosolutions
Tina Fano - Executive Vice President, Planetary Health Biosolutions
Claus Crone Fuglsang - Chief Scientific Officer
Conference Call Participants
Alex Jones - Bank of America
Søren Samsøe - SEB
Charles Eden - UBS
Thomas Lind - Nordea
Sebastian Bray - Berenberg
Lars Topholm - Carnegie
Alex Sloane - Barclays
Chetan Udeshi - JPMorgan
André Thormann - Danske Bank
Georgina Fraser - Goldman Sachs
Presentation
Operator
Ladies and gentlemen, welcome to the Novonesis Full Year Financial Statement for 2024 and Annual Report 2024 Conference Call. I'm Youssef, the Chorus Call operator. [Operator Instructions]. The conference must not be recorded for publication or for broadcast. At this time it's my pleasure to hand over to Tobias Cornelius Björklund. Please go ahead.
Tobias Cornelius Björklund
Thank you very much, operator and welcome, everyone to the Novonesis conference call relating to the full year performance of 2024. My name is Tobias Björklund, and as I said, I'm heading up Investor Relations here at Novonesis. In this call, our CEO, Ester Baiget; and our CFO, Rainer Lehmann will review our pro forma performance for the year as well as the outlook for 2025.
Attending today's call we also have Jacob Paulsen, EVP of Food & Beverage Biosolutions; Amy Byrick, EVP of Human Health Biosolutions; Tina Fano, EVP of Planetary Health Biosolutions; and Claus Crone Fuglsang, Chief Scientific Officer. The conference call will take about one hour including Q&A.
Please change to the next slide and this is to remind you that the information presented during the call is unaudited and that management may make forward-looking statements. These statements are based on current expectations and beliefs and they involve risks and uncertainties that could cause actual results to differ materially from those described in any forward-looking statement.
With that, I will now hand you over to our CEO, Ester Baiget. Ester, please.
Ester Baiget
Thank you. Thank you, Tobias and welcome everyone. Thank you for joining us this morning. Could you please turn to Slide number 3? Thank you. I would like to start off with expressing my sincere gratitude to all of our stakeholders. Thank you to our shareholders for their continued confidence and support. Thank you to our customers and suppliers for their continued partnership. And I really want to extend a special thank you to our incredible employees. Your unwavering commitment and continued focus on customer centricity have been crucial to the success of the integration.
I would also like to take this opportunity to say a few words about Jacob. It was announced last Friday, that he has decided to take a role at another company. I am excited for him on this opportunity. However, I'm also sad to see him leave. Jacob has been important to Novonesis and he has been a strong leader of the Food & Beverages business, creating an excellent team around him. We're far ahead in the process to find a replacement and we'll let you know soon in more due course.
Jacob, who's sitting here with us in the room, Jacob my sincere thank you to you for your time and for your significant contribution to Novonesis. We will miss you Jacob but also we wish you all the very, very, very, best....
Novonesis A/S (NVZMF) Q4 2024 Earnings Call Transcript